AR SB140 | 2025 | 95th General Assembly

Status

Spectrum: Partisan Bill (Republican 2-0)
Status: Introduced on January 29 2025 - 25% progression
Action: 2025-02-05 - Re-referred to INSURANCE & COMMERCE - SENATE
Pending: Senate Insurance & Commerce Committee
Text: Latest bill text (Draft #1) [PDF]

Summary

To Mandate The Use Of Biosimilar Medicines Under Health Benefit Plans; To Require A Healthcare Provider To Prescribe Biosimilar Medicines; And To Improve Access To Biosimilar Medicines.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

To Mandate The Use Of Biosimilar Medicines Under Health Benefit Plans; To Require A Healthcare Provider To Prescribe Biosimilar Medicines; And To Improve Access To Biosimilar Medicines.

Sponsors


History

DateChamberAction
2025-02-05SenateRe-referred to INSURANCE & COMMERCE - SENATE
2025-02-05SenateREPORTED CORRECTLY ENGROSSED
2025-02-05SenateAmendment # 1 read the first time, rules suspended, read the second time and adopted, ordered engrossed.
2025-02-05SenateWithdrawn from Committee and placed on 2nd reading for purpose of amendment # 1
2025-01-29SenateRead first time, rules suspended, read second time, referred to INSURANCE & COMMERCE - SENATE
2025-01-29SenateFiled

Arkansas State Sources


Bill Comments

feedback